Nigeria's NAFDAC Bolsters US Medical Supply Safety with Tech Tracking Amid Concerns

Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) has moved swiftly to quell public anxieties, reassuring Nigerians that all medical supplies from the United States, particularly those destined for critical HIV/AIDS programs, will undergo rigorous safety checks and be meticulously monitored. This decisive clarification comes amidst growing concerns over the US-Nigeria government-to-government (USG-GoN) medical agreement and the perception that it might bypass local regulatory oversight, a notion NAFDAC Director-General, Professor Mojisola Christianah Adeyeye, has firmly debunked. The agency is now deploying its advanced track-and-trace technology to ensure accountability from manufacturer to patient. The stakes are high as these US-donated supplies are crucial for plugging gaps in HIV/AIDS treatment services left by the United States Agency for International Development (USAID)'s exit. While NAFDAC confirms that US-manufactured products approved by the stringent US Food and Drug Administration (FDA) may benefit from an expedited 'regulatory-reliance framework,' it explicitly retains full authority for independent testing of all non-US-made products. The agency has been battling the menace of counterfeit drugs, with significant seizures and investigations ongoing, making robust oversight of all imports, regardless of origin, paramount for public health security. Moving forward, NAFDAC technology-driven Traceability Information System (TIS), which previously proved effective during the COVID-19 vaccine distribution, will now extend its reach to these US-Nigeria medical supplies, including narcotics and maternal health products, guaranteeing their journey across the country. The agency solidified this commitment in July 2026 by making compliance with its Pharmaceutical Products (Traceability) Regulations, 2024, a mandatory requirement for Marketing Authorisation. This proactive stance aims not only to bolster medicine safety but also to rebuild public trust in the integrity of Nigeria's essential healthcare supply chain.